Atlantic Research Group Joins Zymewire’s COVID Collaborators
April 1, 2020Atlantic Research Group (ARG) has joined COVID Collaborators. Assembled by the team at Zymewire, COVID Collaborators is a directory of all the expertise, discounted or free services that the drug development service provider ecosystem is offering to researchers in the global fight against the COVID-19.
ARG is offering free general feasibility guidance as well as discounts on our full suite of services. Consistent investments in technology and communications over time have led to cloud-based systems that will allow us to remotely perform all project management, data management, statistics, medical monitoring, and drug safety tasks--in start-up, maintenance, and close-out. These capacities are valuable during this challenging period.
Zymewire, partner of ARG, further describes the directory: “Thousands of service providers around the globe play a part everyday in getting new drugs to patients. This ecosystem of companies has the expertise, skills, and production facilities that help drug development innovators move quickly through the complex regulatory and scientific pathway. Some of their areas of speciality include clinical research, clinical software, electronic data capture (EDC), manufacturing, patient recruitment, virtual services, and clinical trial management.”
ARG, founded in 2004 with the conviction that everyone deserves to be well, is grateful for the opportunity to participate in the program and be listed in the COVID Collaborators directory.
